These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8096560)

  • 1. Long-term malaria prophylaxis with weekly mefloquine.
    Lobel HO; Miani M; Eng T; Bernard KW; Hightower AW; Campbell CC
    Lancet; 1993 Apr; 341(8849):848-51. PubMed ID: 8096560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen.
    Lobel HO; Bernard KW; Williams SL; Hightower AW; Patchen LC; Campbell CC
    JAMA; 1991 Jan; 265(3):361-4. PubMed ID: 1984534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.
    Weiss WR; Oloo AJ; Johnson A; Koech D; Hoffman SL
    J Infect Dis; 1995 Jun; 171(6):1569-75. PubMed ID: 7769294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
    Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D
    Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K; Petersen E
    J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
    Barrett PJ; Emmins PD; Clarke PD; Bradley DJ
    BMJ; 1996 Aug; 313(7056):525-8. PubMed ID: 8789977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa.
    Wetsteyn JC; de Geus A
    BMJ; 1993 Oct; 307(6911):1041-3. PubMed ID: 8123120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
    Carme B; Peguet C; Nevez G
    Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance and tolerability of mefloquine and chloroquine plus proguanil for long-term malaria chemoprophylaxis in groups at particular risk (the military).
    Peragallo MS; Sabatinelli G; Sarnicola G
    Trans R Soc Trop Med Hyg; 1999; 93(1):73-7. PubMed ID: 10492796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
    Reyburn H; Behrens RH; Warhurst D; Bradley D
    Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian army standpoint on malaria chemoprophylaxis.
    Peragallo MS
    Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mefloquine for malaria chemoprophylaxis 1992-1998: a review.
    Schlagenhauf P
    J Travel Med; 1999 Jun; 6(2):122-33. PubMed ID: 10381965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria chemoprophylaxis.
    Milord F; Allard R; Gyorkos TW
    Lancet; 1993 Aug; 342(8869):502. PubMed ID: 8102463
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers' health.
    Lobel HO; Varma JK; Miani M; Green M; Todd GD; Grady K; Barber AM
    Am J Trop Med Hyg; 1998 Jul; 59(1):129-32. PubMed ID: 9684640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.